Abstract
Methods are described for the characterization of CD34 antigen modulation and its relationship to cell proliferation in early human hematopoietic cells. Toward that end, quiescent primitive CD34+ and CD34NEG cells are purified from mobilized peripheral blood (MoPB). Unlike CD34NEG cells from other sources, those from MoPB grow readily in stroma-free culture, facilitating their analysis. Using a lineage-depleted, low-density mononuclear cell fraction, CD34NEGCD38NEGLINNEG and CD34+CD38NEGLINNEG cells are purified by cell sorting. Cells are cultured in serum-free medium supplemented with early acting cytokines. Up- and down-modulation of CD34 antigen can be observed within 40 h of incubation. Samples are removed for analysis of expression of CD34, CD38 and lineage-commitment antigens as well as for cell proliferation as determined by expression of Ki67 antigen and uptake of pyronin Y. This approach permits an assessment of changes in CD34 and CD38 antigen expression by primitive LINNEG cells as they are activated for growth or remain in a quiescent state.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Simmons, P. J., Levesque, J. P., and Haylock, D. N. (2001) Mucin-like molecules as modulators of the survival and proliferation of primitive hematopoietic cells. Ann. NY Acad. Sci. 938, 196–206.
Civin, C. I., Strauss, L. C, Brovall, C, Fackler, M., Schwartz, J., and Shaper, J. (1984) Antigenic analysis of hematopoiesis II. Hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against Kg1a cells. J. Immunol. 133, 157–165.
Chang, H., Jensen, L., Quesenberry, P., and Bertoncello, I. (2000) Standardization of hematopoietic stem cell assays: a summary of workshops and working group meeting sponsored by National Heart Lung and Blood Institute held at the National Institutes of Health, Bethesda, MD, on September 8–9, 1998 and July 30, 1999. Exp. Hematol. 28, 743–752.
Civin, C. I., Almeida-Porada, G., Lee, M-J., Olweus, J., Terstappen, L. W. M. M., and Zanjani, E. D. (1996) Sustained, retransplantable multilineage engraftment of highly purified adult bone marrow stem cells in vivo. Blood 88, 4102–4109.
Michallet, M., Philip, T, Philip, I., et al. (2000) Transplantation with selected autologous peripheral blood CD34+ Thy1+ hematopoietic stem cells (HSC) in multiple myeloma: impact of HSC dose on engraftment, safety and immune reconstitution. Exp. Hematol. 28, 858–870.
Osawa, M., Hanada, K., Hamada, H., and Nakauchi, H. (1996) Long-term lymphohematopoietic reconstitution by a single CD34NEG hematopoietic stem cell. Science 273, 242–244.
Zanjani, E. D., Almeida-Porada, G., Livingstone, A., Flake, A., and Ogawa, M. (1998) Human bone marrow CD34− cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp. Hematol. 26, 353–360.
Verfaillie, C, Almeida-Porada, G., Wissink, S., and Zanjani, E. (2000) Kinetics of engraftment of CD34− and CD34+ cells from mobilized blood differs from that of CD34− and CD34+ cells from bone marrow. Exp. Hematol. 28, 1071–1079.
Gallacher, L., Murdoch, B., Wu, D., Karanu, F., Fellows, F., and Bhatia, M. (2000) Identification of novel circulating human embryonic blood stem cells. Blood 96, 1740–1747.
Bhatia, M., Bonnet, D., Murdoch, B., Gan, O., and Dick, J. E. (1998) A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 4, 1038–1045.
Engelhardt, M., Lubbert, M., and Guo, Y. (2002) CD34+ or CD34NEG: which is the more primitive? Leukemia 16, 1603–1608.
Ando, K. (2002) Human CD34NEG hematopoietic stem cells: basic features and clinical relevance. Int. J. Hematol. 75, 370–375.
Bonnet, D. (2001) Normal and leukemic CD34NEG human hematopoietic stem cells. Rev. Clin. Exp. Hematol. 5, 42–61.
Kim, D. K., Fujiki, Y., Fukushima, T., Ema, H., Shibuya, A., and Nakauchi, H. (1999) Comparison of hematopoietic activies of human bone marrow and umbilical cord blood CD34 positive and negative cells. Stem Cells 17, 286–294.
Nakamura, Y, Ando, K, Chargui, J., et al. (1999) Ex vivo generation of CD34+ cells from CD34− hematopoietic cells. Blood 94, 4053–4059.
Gallacher, L., Murdoch, B., Wu, D., Karanu, F., Keeney, M., and Bhatia, M. (2000) Isolation and characterization of human CD34−Lin− and CD34+Lin− hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95, 2813–2819.
Ladd, A., Pyatt, R., Gothot, A., et al. (1997) Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0. Blood 90, 658–668.
Gothot, A., Pyatt, R., McMahel, J., Rice, S., and Srour, E. (1997) Functional heterogeneity of human CD34+ cells isolated in subcompartments of the G0/G1 phase of the cell cycle. Blood 90, 4384–4393.
Gerdes, J., Lemke, H., Baisch, H., Wacker, H., Schwab, U., and Stein, H. (1984) Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710–1715.
Shapiro, H. (1995) Practical Flow Cytometry, 3rd edit. Wiley-Liss, New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Dooley, D.C., Oppenlander, B.K. (2004). Phenotypic and Functional Analyses of CD34NEG Hematopoietic Precursors From Mobilized Peripheral Blood. In: Hawley, T.S., Hawley, R.G. (eds) Flow Cytometry Protocols. Methods in Molecular Biology™, vol 263. Humana Press. https://doi.org/10.1385/1-59259-773-4:201
Download citation
DOI: https://doi.org/10.1385/1-59259-773-4:201
Publisher Name: Humana Press
Print ISBN: 978-1-58829-234-6
Online ISBN: 978-1-59259-773-4
eBook Packages: Springer Protocols